14 / 35
RET
rearrangements
•
Observed in 1-2% NSCLC
•
Most common in never smokers and advanced disease.
•
Promised clinical results with highly selected RET inhibitors
|
|
14 / 35
14 / 35
RET
rearrangements
•
Observed in 1-2% NSCLC
•
Most common in never smokers and advanced disease.
•
Promised clinical results with highly selected RET inhibitors